Source: Eur Respir J 2003 Dec 01;22(6):874-875



Rating:

Share or cite this content

Citations should be made in the following way:
Rabe K.F.. Combination therapy for chronic obstructive pulmonary disease: one size fits all?. Eur Respir J 2003 Dec 01;22(6):874-875

Member's Comments

No comment yet.

Related content which might interest you: Emerging anti-inflammatory strategies for COPD}, Source: Eur Respir J 2012; 40: 724-741 Year: 2012 Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits? Source: ERJ Open Res, 6 (2) 00099-2020; 10.1183/23120541.00099-2020 Year: 2020 Chronic obstructive pulmonary disease and tuberculosis: phenotypes, options Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Mechanisms in chronic obstructive pulmonary disease: comparisons with asthma Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Chronic obstructive pulmonary disease (COPD) in children: is it possible? Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 Targeted therapy in eosinophilic chronic obstructive pulmonary disease Source: ERJ Open Res, 7 (2) 00437-2020; 10.1183/23120541.00437-2020 Year: 2021 Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes Source: Eur Respir J 2003; 21: 30S-35S Year: 2003 Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Source: Guideline 1995 Year: 1995 Introduction: systemic effects in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 1S Year: 2003 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 903-908 Year: 2001 Inferon efficacy in the treatment of chronic obstructive pulmonary disease Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Modern treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 60S-66S Year: 2001 Managing deteriorations in chronic obstructive pulmonary disease: which organ is failing? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018 Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007